KN Stock Analysis: Knowles Cor | NYSE
Electronic Components | NYSE, USA | Market Cap: 2.919m USD | 12M Return: 64.2% | US49926D1090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.2M
EPS Trend: 79.1%
Qual. Beats: 2
Rev. Trend: 42.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Knowles Corporation (NYSE: KN) is a U.S.-based electronic components company operating through two segments: Precision Devices (PD), which supplies capacitors and RF solutions for defense, industrial, medtech, and electrification/energy applications, and Medtech & Specialty Audio (MSA), which produces balanced armature speakers and microphones primarily for hearing health and other specialty audio markets. Founded in 1946 and headquartered in Itasca, Illinois, the company manufactures film, electrolytic, and mica capacitors and serves customers including OEMs and their contract manufacturers, suppliers, sales representatives, and distributors across the Americas, Europe, and Asia.
Within the Information Technology sector (Electronic Components sub-industry), Knowles occupies a specialized niche in high-reliability passive components and acoustic transducers. Its balanced armature technology is widely used in hearing aids, giving the MSA segment a meaningful position in the global hearing health device supply chain.
- Precision Devices revenue grows on defense and electrification demand
- MSA segment margins expand as hearing health market recovers
- Film and electrolytic capacitor demand rises with EV and energy adoption
| Net Income: 67.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -4.16 > 1.0 |
| NWC/Revenue: 35.12% < 20% (prev 29.76%; Δ 5.35% < -1%) |
| CFO/TA 0.10 > 3% & CFO 103.8m > Net Income 67.5m |
| Net Debt (119.8m) to EBITDA (130.5m): 0.92 < 3 |
| Current Ratio: 3.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.9m) vs 12m ago 0.34% < -2% |
| Gross Margin: 42.28% > 18% (prev 40.19%; Δ 2.10% > 0.5%) |
| Asset Turnover: 58.68% > 50% (prev 51.74%; Δ 6.94% > 0%) |
| Interest Coverage Ratio: 12.79 > 6 (EBIT TTM 93.4m / Interest Expense TTM 7.30m) |
| A: 0.21 (Total Current Assets 324.3m - Total Current Liabilities 101.3m) / Total Assets 1.08b |
| B: -0.50 (Retained Earnings -540.3m / Total Assets 1.08b) |
| C: 0.09 (EBIT TTM 93.4m / Avg Total Assets 1.08b) |
| D: 2.84 (Book Value of Equity 795.5m / Total Liabilities 280.5m) |
| Altman-Z'' = 3.28 = A |
| DSRI: 1.02 (Receivables 116.5m/101.1m, Revenue 635.0m/563.1m) |
| GMI: 0.95 (GM 40.19% / 42.28%) |
| AQI: 0.98 (AQ_t 0.55 / AQ_t-1 0.56) |
| SGI: 1.13 (Revenue 635.0m / 563.1m) |
| TATA: -0.03 (NI 67.5m - CFO 103.8m) / TA 1.08b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of September 02, 2026, the stock is trading at USD 34.33 with a total of 798,303 shares traded. Over the past week, the price has changed by +2.05%, over one month by -8.40%, over three months by -9.20% and over the past year by +64.18%.
Current recommended Stop Loss: 32.50 (which is 5.3% or 1.2 ATR below the current price).
Knowles Cor has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy KN.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43.8 | 27.4% |
P/E Trailing = 40.6905
P/E Forward = 15.2439
P/S = 4.5974
P/B = 3.7535
P/EG = 0.43
Revenue TTM = 635.0m USD
EBIT TTM = 93.4m USD
EBITDA TTM = 130.5m USD
Long Term Debt = 131.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.50m USD (from shortTermDebt, last quarter)
Debt = 169.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 19.2m
Net Debt = 119.8m USD (calculated: Debt 169.4m - CCE 49.6m)
Enterprise Value = 3.04b USD (2.92b + Debt 169.4m - CCE 49.6m)
Interest Coverage Ratio = 12.79 (Ebit TTM 93.4m / Interest Expense TTM 7.30m)
EV/FCF = 47.86x (Enterprise Value 3.04b / FCF TTM 63.5m)
FCF Yield = 2.09% (FCF TTM 63.5m / Enterprise Value 3.04b)
FCF Margin = 10.0% (FCF TTM 63.5m / Revenue TTM 635.0m)
Net Margin = 10.63% (Net Income TTM 67.5m / Revenue TTM 635.0m)
Gross Margin = 42.28% ((Revenue TTM 635.0m - Cost of Revenue TTM 366.5m) / Revenue TTM)
Gross Margin QoQ = 42.39% (prev 41.28%)
Tobins Q-Ratio = 2.82 (Enterprise Value 3.04b / Total Assets 1.08b)
Interest Expense / Debt = 4.31% (Interest Expense 7.30m / Debt 169.4m)
Taxrate = 14.39% (12.3m / 85.5m)
NOPAT = 80.0m (EBIT 93.4m * (1 - 14.39%))
Current Ratio = 3.20 (Total Current Assets 324.3m / Total Current Liabilities 101.3m)
Debt / Equity = 0.21 (Debt 169.4m / totalStockholderEquity, last quarter 795.5m)
Debt / EBITDA = 0.92 (Net Debt 119.8m / EBITDA 130.5m)
Debt / FCF = 1.89 (Net Debt 119.8m / FCF TTM 63.5m)
Total Stockholder Equity = 775.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.24% (Net Income 67.5m / Total Assets 1.08b)
RoE = 8.70% (Net Income TTM 67.5m / Total Stockholder Equity 775.8m)
RoCE = 10.30% (EBIT 93.4m / Capital Employed (Equity 775.8m + L.T.Debt 131.0m))
RoIC = 8.44% (NOPAT 80.0m / Invested Capital 947.5m)
WACC = 11.52% (E(2.92b)/V(3.09b) * Re(11.97%) + D(169.4m)/V(3.09b) * Rd(4.31%) * (1-Tc(0.14)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.30 | Cagr: -1.29%
[DCF] Terminal Value 62.27% ; FCFF base≈81.9m ; Y1≈71.8m ; Y5≈58.0m
[DCF] Fair Price = 5.79 (EV 614.3m - Net Debt 119.8m = Equity 494.5m / Shares 85.4m; r=11.52% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 79.11 | EPS CAGR: 9.54% | SUE: 2.25 | # QB: 2
Revenue Correlation: 42.79 | Revenue CAGR: 2.92% | SUE: 0.19 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.36 | Chg30d=+5.93% | Revisions=+57% | Analysts=4
EPS current Year (2026-12-31): EPS=1.33 | Chg30d=+3.29% | Revisions=+57% | GrowthEPS=+20.3% | GrowthRev=+12.4%
EPS next Year (2027-12-31): EPS=1.62 | Chg30d=+3.85% | Revisions=+29% | GrowthEPS=+21.2% | GrowthRev=+6.9%
[Analyst] Revisions Ratio: +67% (up=11, down=1)